Rigetti Inks $100M CHIPS Act Deal to Accelerate Quantum R&D
RGTI sits 27% above its 52-week low of $12.53.
Summary
Rigetti signed a definitive agreement with the U.S. Department of Commerce for a $100 million award under the CHIPS Act to fund three R&D projects targeting key bottlenecks in superconducting quantum computing: miniaturized readout electronics, expanded cryogenic capacity, and high-connectivity chip fabrication. The agreement provides $43.9 million initially, then $29.9 million and $26.2 million tranches upon milestone completion. The deal includes a minority, non-controlling equity stake for the government, with Rigetti issuing 7,739,938 shares at $12.92 per share, adding modest dilution. This is a major non-dilutive capital infusion relative to the company's $5.1 million quarterly revenue and $52.6 million net loss, and it validates Rigetti's technology roadmap with government backing. The funding should extend runway and accelerate development toward utility-scale systems. Watch for milestone-based disbursement details and any additional government partnerships.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — The agreement provides $43.9M initially, then $29.9M and $26.2M tranches upon milestone completion. Rigetti will issue 7,739,938 shares to the government at $12.92 per share.
At the time of this announcement, RGTI was trading at $15.97 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $12.53 to $58.15. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.